Louis DeSantis

1.8k total citations
41 papers, 1.4k citations indexed

About

Louis DeSantis is a scholar working on Ophthalmology, Molecular Biology and Physiology. According to data from OpenAlex, Louis DeSantis has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Ophthalmology, 16 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Louis DeSantis's work include Glaucoma and retinal disorders (18 papers), Nitric Oxide and Endothelin Effects (10 papers) and Retinal Development and Disorders (9 papers). Louis DeSantis is often cited by papers focused on Glaucoma and retinal disorders (18 papers), Nitric Oxide and Endothelin Effects (10 papers) and Retinal Development and Disorders (9 papers). Louis DeSantis collaborates with scholars based in United States, China and United Kingdom. Louis DeSantis's co-authors include Neville N. Osborne, Ronald S. Harwerth, John P. M. Wood, Debra L. Shade, Iok-Hou Pang, H. Thomas Steely, Marsha A. McLaughlin, Abbot F. Clark, Glyn Chidlow and Ana Luı́sa Carvalho and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and European Journal of Pharmacology.

In The Last Decade

Louis DeSantis

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis DeSantis United States 23 957 644 262 223 168 41 1.4k
Guadalupe Ruíz United States 14 996 1.0× 867 1.3× 203 0.8× 322 1.4× 83 0.5× 47 1.5k
Ernst H. Bárány Sweden 21 1.2k 1.2× 634 1.0× 382 1.5× 231 1.0× 198 1.2× 78 1.9k
Giedrius Kalesnykas Finland 19 410 0.4× 483 0.8× 176 0.7× 142 0.6× 133 0.8× 56 1.1k
Jorge L. Cueva Vargas Canada 12 838 0.9× 745 1.2× 228 0.9× 180 0.8× 97 0.6× 18 1.3k
Douglas S. Gregory United States 17 354 0.4× 363 0.6× 107 0.4× 276 1.2× 123 0.7× 28 830
Samantha Carreiro United States 11 266 0.3× 427 0.7× 57 0.2× 101 0.5× 97 0.6× 21 827
Susana del Olmo‐Aguado Spain 14 320 0.3× 453 0.7× 183 0.7× 210 0.9× 98 0.6× 30 927
Yasunari Munemasa Japan 22 655 0.7× 718 1.1× 237 0.9× 209 0.9× 96 0.6× 47 1.3k
Xiaoxi Qiao United States 20 434 0.5× 1.2k 1.8× 137 0.5× 699 3.1× 98 0.6× 44 1.9k

Countries citing papers authored by Louis DeSantis

Since Specialization
Citations

This map shows the geographic impact of Louis DeSantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis DeSantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis DeSantis more than expected).

Fields of papers citing papers by Louis DeSantis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis DeSantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis DeSantis. The network helps show where Louis DeSantis may publish in the future.

Co-authorship network of co-authors of Louis DeSantis

This figure shows the co-authorship network connecting the top 25 collaborators of Louis DeSantis. A scholar is included among the top collaborators of Louis DeSantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis DeSantis. Louis DeSantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldstein, Gary, Louis DeSantis, & Charles J. Goodacre. (2020). Bruxism: Best Evidence Consensus Statement. Journal of Prosthodontics. 30(S1). 91–101. 29 indexed citations
2.
Whitson, Jess T., Robert Faulkner, Michael A. Curtis, et al.. (2005). Concentrations of Betaxolol in Ocular Tissues of Patients with Glaucoma and Normal Monkeys after 1 Month of Topical Ocular Administration. Investigative Ophthalmology & Visual Science. 47(1). 235–235. 33 indexed citations
3.
DeSantis, Louis, et al.. (2003). Travoprost: A potent ocular hypotensive agent. Drugs of today. 39(1). 61–61. 30 indexed citations
4.
Osborne, Neville N., John P. M. Wood, Glyn Chidlow, et al.. (2003). Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma. Brain Research Bulletin. 62(6). 525–528. 48 indexed citations
5.
Hellberg, Mark R., Verney L. Sallee, Marsha A. McLaughlin, et al.. (2001). Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist. Journal of Ocular Pharmacology and Therapeutics. 17(5). 421–432. 96 indexed citations
6.
Kulkarni, Prasad S. & Louis DeSantis. (2001). Vasorelaxant Effects of Racemic Betaxolol and its R- and S- Isomers on Bovine Retinal Vessels. Journal of Glaucoma. 10(5). 423–426. 4 indexed citations
7.
Wood, John P. M., Louis DeSantis, Hsiao‐Ming Chao, & Neville N. Osborne. (2001). Topically Applied Betaxolol Attenuates Ischaemia-induced Effects to the Rat Retina and Stimulates BDNF mRNA. Experimental Eye Research. 72(1). 79–86. 72 indexed citations
8.
DeSantis, Louis. (2000). Preclinical Overview of Brinzolamide. Survey of Ophthalmology. 44. S119–S129. 95 indexed citations
9.
Wexler, Eric, et al.. (1999). Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells.. PubMed. 40(6). 1170–6. 29 indexed citations
10.
Yu, Dao‐Yi, Er‐Ning Su, Stephen J. Cringle, et al.. (1999). Systemic and Ocular Vascular Roles of the Antiglaucoma Agents b-Adrenergic Antagonists and Ca2+ Entry Blockers. Survey of Ophthalmology. 43. S214–S222. 29 indexed citations
11.
Kapin, Michael A., Rupali Doshi, B. Scatton, Louis DeSantis, & Michael L. Chandler. (1999). Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.. PubMed. 40(6). 1177–82. 43 indexed citations
12.
Ishikawa, Hitoshi, Louis DeSantis, & Popat N. Patil. (1998). Selectivity of Muscarinic Agonists Including (±)-Aceclidine and Antimuscarinics on the Human Intraocular Muscles. Journal of Ocular Pharmacology and Therapeutics. 14(4). 363–373. 14 indexed citations
13.
Yu, Dao‐Yi, Er‐Ning Su, Stephen J. Cringle, et al.. (1998). Effect of Betaxolol, Timolol and Nimodipine on Human and Pig Retinal Arterioles. Experimental Eye Research. 67(1). 73–81. 52 indexed citations
14.
Chandler, Michael L., Iok‐Hou Pang, Rupali Doshi, et al.. (1997). In vitro and in vivo protective effects of eliprodil in the retina. Investigative Ophthalmology & Visual Science. 38(4). 2 indexed citations
15.
Osborne, Neville N., Chantal Cazevieille, Ana Luı́sa Carvalho, Anna Kirstine Larsen, & Louis DeSantis. (1997). In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Research. 751(1). 113–123. 108 indexed citations
16.
17.
Pang, Iok‐Hou, et al.. (1994). Characterization of Muscarinic Receptor Involvement in Human Ciliary Muscle Cell Function. Journal of Ocular Pharmacology and Therapeutics. 10(1). 125–136. 15 indexed citations
18.
Pang, Iok-Hou, Debra L. Shade, Abbot F. Clark, H. Thomas Steely, & Louis DeSantis. (1994). Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Current Eye Research. 13(1). 51–63. 124 indexed citations
19.
Kalloniatis, Michael, et al.. (1993). Colour vision anomalies following experimental glaucoma in monkeys. Ophthalmic and Physiological Optics. 13(1). 56–67. 24 indexed citations
20.
Danziger, Robert S., Robert A. Star, Shirou Matsumoto, et al.. (1993). Characterization of Soluble Guanylyl Cyclase in Transformed Human Non-pigmented Epithelial Cells. Biochemical and Biophysical Research Communications. 195(2). 958–962. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guadalupe Ruíz Breakdown of academic impact, for papers by Ernst H. Bárány Breakdown of academic impact, for papers by Giedrius Kalesnykas Breakdown of academic impact, for papers by Jorge L. Cueva Vargas Breakdown of academic impact, for papers by Douglas S. Gregory Breakdown of academic impact, for papers by Samantha Carreiro Breakdown of academic impact, for papers by Susana del Olmo‐Aguado Breakdown of academic impact, for papers by Yasunari Munemasa Breakdown of academic impact, for papers by Xiaoxi Qiao
Rankless by CCL
2026